Eve vs Invyncible
Invyncible costs $2.50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Eve and Invyncible, the first difference is cost: Invyncible is $2.50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Invyncible leads our six-part score, 6.6 to 6.5.
Eve vs Invyncible price
Invyncible is the cheaper way in: $192.50 a month against $195 a month at Eve. That is $2.50 less each month (1% lower), or about $30 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Invyncible ($192.50 a month vs $195 a month); tirzepatide is cheaper at Eve ($195 a month vs $210 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Eve prices compounded injections, an oral option and brand-name pens, while Invyncible prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Eve is the only one of the two with a brand-name price.
Where each one treats patients
Eve does not publish where it ships, and Invyncible lists 40 states.
Pricing
Eve
Invyncible
Listed at $192.50 against a $275.00 list price. Programs are sold per vial with an approximate duration, not as a calendar month — see the review notes.
Listed at $210.00 against a $300.00 list price. Cheaper combination formulas exist: tirzepatide/glycine/B12 $180.00 and semaglutide/glycine/B12 $149.00.
What each price covers
Eve's price also covers the clinician visit, the medication itself and shipping, which Invyncible does not claim.
Eve is silent on lab work and coaching.
Invyncible does not say what its price includes.
That matters most for the drug: unless Invyncible confirms otherwise, budget for medication on top of its listed price.
Eve
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Invyncible
Inclusions not disclosed.
Where each one scores higher
Overall, Invyncible scores 6.6 and Eve 6.5 out of 10.
Eve is stronger on value (6.8 vs 6.3) and support (7.0 vs 5.0).
Invyncible is stronger on trust & safety (5.0 vs 4.0) and accessibility (8.4 vs 5.0).
Effectiveness and user experience are within half a point.
Eve
6.5/10
Invyncible
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Eve nor Invyncible has an FDA warning letter on record with us.
Features & Coverage
| Feature | Eve | Invyncible |
|---|---|---|
| Starting Price | $195/mo | ✓$192.50/mo |
| Features | ✓8 features | 6 features |
| States Available | Not disclosed | 40 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Eve
Eve charges $195/mo for compounded GLP-1, with brand-name options starting at $1,399/mo, on a '$0 unless approved' payment model. Its women's-health focus is distinctive in a largely gender-neutral market. The account carries compounded semaglutide and tirzepatide, an oral sublingual form included, plus brand-name Ozempic, Wegovy and Mounjaro. It is LegitScript Certified with a publicly verifiable ID.
Read our full Eve review →About Invyncible
Invyncible does not publish its pricing tiers; they surface only after the sign-up flow. The Florida-based platform sells semaglutide and tirzepatide programs for weight management, openly discloses its corporate parent and physical address where competitors hide ownership behind a trade name, and displays a LegitScript verification seal. There is no long-term commitment.
Read our full Invyncible review →Pros & Cons
Eve
What we like
- Semaglutide costs $195 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $195 a month, 22% below the $250 median for compounded tirzepatide across the sellers we compare
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Eve
- Offers both oral and injectable options, so the format is your choice
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Invyncible
What we like
- Tirzepatide costs $210 a month, 16% below the $250 median for compounded tirzepatide across the sellers we compare
- Serves 40 states
- We found no FDA warning letters issued to Invyncible
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Invyncible wins this one, 6.6 to 6.5, above all for compounded tirzepatide at $210/month. It also costs $2.50 less each month than Eve. Eve fits better if moving between compounded and brand without changing seller is your priority.
Choose Eve if…
You want moving between compounded and brand without changing seller and an opening price near $195 a month.
Choose Invyncible if…
You want compounded tirzepatide at $210/month and an opening price near $192.50 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Eve vs Invyncible: FAQ
Close alternatives to Eve and Invyncible
- Eve vs Healthicare
- Eve vs NuvaHealth
- Eve vs Ark Health
- Eve vs Good Girl Rx
- Invyncible vs Obu Health
- Invyncible vs Welling Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.